1 option
Motor System Disorders. Part II, Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment / David S. Younger.
Elsevier ScienceDirect eBook - Neuroscience 2022 Available
View online- Format:
- Book
- Author/Creator:
- Younger, David S., author.
- Series:
- Issn Series.
- Issn Series
- Language:
- English
- Subjects (All):
- Movement disorders.
- Physical Description:
- 1 online resource (672 pages).
- Edition:
- First edition.
- Place of Publication:
- Amsterdam : Elsevier, [2023]
- Contents:
- Intro
- Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment
- Copyright
- Foreword
- Preface
- Contributors
- Contents
- Spinal cord diseases
- Chapter 1: Spinal cord motor disorders
- Introduction
- Embryology
- Spinal cord
- Vascular system
- Neuroanatomy
- Bony spine
- Vasculature
- Spinal Motor Control
- Supraspinal connections
- Posture and gait integration
- Spinal Cord Lesions
- Spinal cord syndromes in the transverse plane
- Anterior spinal cord
- Anterior horn
- Centromedullary
- Brown-Séquard
- Posterior spinal artery syndrome
- Transverse complete spinal cord syndrome
- Spinal cord syndromes in the longitudinal axis
- Ischemia of the cervical region
- Ischemia of the thoracic region
- Ischemia of the lumbar region
- History and Physical Examination
- Laboratory Evaluation
- Noninvasive spinal cord imaging
- Neurophysiology
- Somatosensory evoked potentials
- Transcranial magnetic stimulation
- Cerebrospinal fluid analysis
- Vascular imaging
- Conventional MRI
- Advanced MRI techniques
- Digital subtraction angiography
- Tumors
- Advances in tumor classification
- Gliomas
- Astrocytomas
- Ependymomas
- Meningiomas
- Metastases
- Lymphoma
- CNS Demyelinating Diseases
- Multiple sclerosis
- NMO-spectrum disorders
- MOG-antibody disease
- Stroke
- Spinal cord infarction
- Vascular malformations
- Arteriovenous fistula
- Arteriovenous malformations
- Cavernous malformations
- Motor Neuron Disease
- Spinal muscular atrophy
- Progressive muscular atrophy
- Primary lateral sclerosis
- Poliomyelitis
- Spinal Cord Injury
- Intramedullary insults
- Muscle and motor neuron excitability
- Short- and long-term potentiation and depression
- Implications for neural plasticity
- Collateral sprouting
- Regeneration.
- Future Research
- References
- Chapter 2: Childhood spinal muscular atrophy
- History
- Classification
- Epidemiology
- SMA type 1
- SMA type 2
- SMA type 3
- SMA type 4
- Genetics
- Other Forms of Spinal Muscular Atrophy
- Very severe SMA
- SMA-plus types
- Etiopathogenesis
- SMN protein
- Neurofilaments
- SMN2 copy number
- Splicing regulators as modifiers of phenotype
- Epigenetic modifications: Methylation
- Electrophysiological biomarkers
- Neuroimaging
- Management
- Natural History and Prognosis
- Disease-Modifying Molecular Therapy
- Nusinersen, antisense oligonucleotide treatment to promote full-length SMN protein
- Onasemnogene
- Risdiplam
- Conclusion and Future Directions
- Chapter 3: The hereditary spastic paraplegias
- Introduction11Abbreviations used in the chapter are listed at the end of the chapter before References section.
- Definitions
- Simplex Cases
- Clinical Presentation
- Illustrative cases
- Uncomplicated spastic paraplegia
- Insidiously progressive spastic gait
- Cerebral palsy phenotype
- Infantile-onset, nonprogressive spastic gait
- Primary lateral sclerosis phenotype
- Spastic ataxia phenotype
- Spastic paraplegia with distal muscle wasting
- Developmental delay, intellectual impairment, dysarthria, spastic paraparesis or quadriparesis
- Complex neurodegenerative disorders that include spastic paraparesis
- Clinical Aspects and Disease Course
- Neurologic findings in subjects with ``uncomplicated´´ HSP
- Weakness
- Spasticity
- Mild impairment of distal vibration perception
- Hyperreflexia
- Reduced speed of muscle activation
- Gait
- Stance
- Forward-shifted foot strike and toe walking
- Hip flexion is often reduced (or slightly delayed).
- Knee adduction and incomplete extension
- Upper extremities
- Diagnosis
- Differential diagnosis
- Diagnostic evaluation
- Routine laboratory testing
- Genetic Testing
- Genetic Counseling
- Neuropathology (Schwarz, 1952
- Schwarz and Liu, 1956
- Behan and Maia, 1974
- Sack et al., 1978
- Buge et al., 1979
- Harding
- Genetic Basis
- Treatment and Prognosis
- Spasticity treatment
- Medication
- Orthotics
- Physical therapy
- Prognosis
- Conclusions
- Future Directions
- Acknowledgments
- Chapter 4: Primary lateral sclerosis
- Clinical Description
- Neuropathology
- Electrophysiology
- MRI
- Positron emission tomography
- Differential Diagnosis
- Neurodegeneration and Relation to Motor Neuron Disease
- Genetics of Primary Lateral Sclerosis
- Treatment
- Chapter 5: Transverse myelitis in children and adults
- Infectious Myelitis
- Bacterial myelitis
- Viral myelitis
- Fungal myelitis
- Parasitic
- Noninfectious Myelitis
- Neuromyelitis optica spectrum disorders
- Acute disseminated encephalomyelitis
- Myelin oligodendrocyte glycoprotein-antibody-associated disease
- Idiopathic Myelitis
- Transverse Myelitis and Vaccines
- Systemic Disorders
- Sarcoidosis
- Systemic lupus erythematosus
- Paraneoplastic myelitis
- Radiation therapy-related myelitis
- Toxic-metabolic vascular mimickers
- Chapter 6: Multiple sclerosis: Motor dysfunction
- Epidemiology and Etiopathogenic Factors
- Clinical motor dysfunction
- MS Variants: AQP4, NMOSD, and MOGAD
- Childhood MS
- Clinical features
- Pediatric NMO and MOG serology
- MRI findings
- Pathology
- Gross and microscopic pathology.
- Immunopathology
- Pharmacotherapy
- Disease-modifying therapy
- Assessing motor disability
- Rehabilitation
- Adaptive equipment
- Symptomatic therapy
- Exercise
- Increasing neural plasticity
- Endocannabinoid signaling
- Cytokine signaling
- Receptor signaling
- Chapter 7: Tropical spastic paraparesis
- Tropical Myelopathy
- Acute tropical myeloneuropathy
- Transverse myelitis
- Chronic Tropical Myelopathy
- Tropical spastic paraparesis
- Tropical Neuropathy
- Strachan syndrome
- Beriberi
- Toxic Neuropathy
- Neurologic Disorders Associated With Dietary Cyanide Intoxication
- Progressive neurodegenerative diseases
- Chapter 8: Cerebellum: From the identification of the cerebellar motor syndrome to the internal models
- Introduction: History of Cerebellar Research Since the 18th Century1
- Anatomy: Microscopy and Macroscopy
- Cellular Physiology
- Simple spikes and complex spikes
- Rebound depolarization and disinhibition
- Plasticity mechanisms
- Cerebro-Cerebellar Structural Connectivity
- Cerebello-Cortical Circuits: Neurophysiological Aspects
- The Three Clinical Syndromes to the Light of Internal Models
- Competing interests
- Ethical committee request
- Chapter 9: Synucleinopathies
- Historical Perspective
- Pure Autonomic Failure
- Pathophysiology
- Clinical features (Fig. 9.1)
- Neurogenic orthostatic hypotension and supine hypertension
- Gastrointestinal dysfunction
- Genitourinary dysfunction
- Thermoregulatory dysfunction
- Anosmia
- Dream enactment behavior
- Other clinical manifestations
- Ancillary testing
- Autonomic function tests
- Laboratory testing and evaluation of end-organ damage
- Catecholamine studies
- Neuroendocrine studies.
- Cardiac sympathetic neuroimaging
- Urodynamic studies and gastrointestinal studies
- Skin biopsy
- Analysis of cerebrospinal fluid
- Care team
- Symptom management
- Prognosis and phenoconversion
- Multiple System Atrophy
- Diagnostic criteria
- Motor features
- Nonmotor features
- Survival
- Paraclinical testing
- Autonomic cardiovascular domain
- Plasma catecholamines
- Thermoregulatory domain
- Urogenital, gastrointestinal, and respiratory domains
- Brain imaging
- Cardiac sympathetic neuroimaging
- Multidisciplinary approach
- Motor symptoms
- Nonmotor symptoms
- Disease-modifying approaches (Fig. 9.4)
- Lewy Body Disorders-Parkinson Disease and Dementia with Lewy Bodies
- Imaging techniques
- Autonomic testing
- Others
- Chapter 10: Amyotrophic lateral sclerosis
- Genetic Basis of ALS
- Cu/Zn-superoxide dismutase
- C9orf72
- TARDBP
- Fused in sarcoma
- Optineurin
- Valsolin-containing protein
- Dynactin
- Senataxin
- GLE1, RNA export mediator
- UBQLN2, PFN1, and VAPB
- Disease Pathogenesis
- Instability of mutant proteins
- SOD1
- Disrupted RNA metabolism
- SCA36
- Defective axonal cytoskeletal and transport
- DCTN1
- Profilin-1
- Other putative disease mechanisms
- Defective autophagy
- ER stress and impaired degradation (SOD1, OPTN).
- Notes:
- Prion-like spread.
- Description based on print version record.
- ISBN:
- 0323958559
- 9780323958554
- 0323988172
- 9780323988179
- OCLC:
- 1427669421
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.